View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Olga Smolentseva
  • Olga Smolentseva

Clinical updates at AACR and cash runway into 2024

Transgene reported FY 2022 financial results and provided a corporate update. The financial figures were largely in line with expectations. The Company reported a net loss of EUR 32.8m in 2022 (vs EUR 19.5m in 2021), including an R&D spend of EUR 32.2m (vs EUR 32.9m in 2021). At the end of 2022

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch